Nuveen
ORMP icon

Nuveen’s Oramed Pharmaceuticals ORMP Stock Holding History

Nuveen’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$223K Buy
+46,404
New +$185K ﹤0.01% 3606
2022
Q2 		– Sell
-154,729
Closed -$1.46M – 3424
2022
Q1 		$1.46M Sell
154,729
-3,911
-2% -$40.1K ﹤0.01% 2658
2021
Q4 		$2.27M Buy
158,640
+66,859
+73% +$1.4M ﹤0.01% 2513
2021
Q3 		$1.88M Sell
91,781
-160
-0.2% -$2.73K ﹤0.01% 2699
2021
Q2 		$1.23M Buy
+91,941
New +$1.05M ﹤0.01% 2929

Other funds holding ORMP

Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $80.9B AUM 26.08% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.81B AUM 38.21% 1-Year Est. Return
GIA
Gem Investment Advisors Teaneck, New Jersey $163M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $725M AUM 82.02% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nuveen's ORMP Position: Q2 2026 in Review

Nuveen opened a new position in Oramed Pharmaceuticals (ORMP) in Q2 2026: 46,404 shares worth $223K. The stake represents ﹤0.01% of the portfolio and ranks #3606 among its holdings. This is a return to the name: Nuveen previously reported a position in ORMP as recently as Q1 2022.

Nuveen first reported a position in ORMP in Q2 2021 and has held it in 5 quarters since. The position peaked at $2.27M in Q4 2021. 84 funds tracked by Wall St. Rank hold ORMP as of Q2 2026.

  • Nuveen held 46,404 shares of Oramed Pharmaceuticals worth $223K as of Q2 2026.
  • Oramed Pharmaceuticals was a new Nuveen position in Q2 2026.
  • Oramed Pharmaceuticals made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #3606 holding.
  • Nuveen first reported a position in Oramed Pharmaceuticals in Q2 2021 and has held it in 5 quarters since.
  • Nuveen's Oramed Pharmaceuticals position peaked at $2.27M in Q4 2021.
  • 84 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.